Atlas Trials

Exploring Relevant Immune-based Biomarkers and Circulating Tumor Cells During Treatment With Immunotherapy in Genitourinary Malignancies (CTC Immune Based Biomarkers)

Clinical trial NCT02978118 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT02978118
Sponsor
Duke University
Status
ACTIVE_NOT_RECRUITING
Study type
OBSERVATIONAL
Carcinoma, Renal CellCarcinoma, Urothelial
Start date
2017-03-07
Primary completion
2028-10-01
Enrollment
67

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.